Whitehall Foundation

As of July 2026, eligibility is restricted exclusively to researchers at the assistant professor level, with a preference for those just beginning their careers.

Deadline:  Letter of intent due October 1, 2026. If invited, full application due February 15, 2027.

Funding:
Up to $300,000. The maximum budget is $100,000 per year for the two- and three-year research grants.

Purpose:
Research grants are available to investigators that meet all of the foundation’s eligibility requirements and are working at accredited institutions in the United States. Applications will be judged on the scientific merit and the innovative aspects of the proposal, as well as on the competence of the applicant. Research grants of up to three years will be provided. A renewal grant with a maximum of two years is possible, but it will be awarded on a competitive basis. Research grants will not be awarded to investigators who have already received, or expect to receive, substantial support from other sources, even if it is for an unrelated purpose. The maximum budget is $100,000 per year for the two- and three-year research grants.

Eligibility
The applicant must meet all four of the following eligibility requirements in order to participate in the application process:

1. Appropriate title – must hold the title of assistant professor. If the institution does not use this title, a letter from the department chair confirming the applicant's eligibility is required.
2. Independence – to be eligible for consideration an applicant must be considered an "independent investigator," as defined by the National Institutes of Health. The foundation assesses independence based on the faculty appointment, commitment of the institution to the PI as an individual member of the faculty, and the allocation of lab space that is independent and free from the control of other members of the faculty. Each application will be assessed on its own merits, but our emphasis on independence is particularly important when an applicant is continuing at the same institution as their doctoral or postdoctoral advisor. Please note that the foundation does not consider lab space located within a former mentor’s or advisor's lab to be sufficiently independent, even with the title of assistant professor or assistant research professor. These expectations are in line with the foundation’s goal of supporting young investigators as they launch their careers.
3. Status – must hold principal investigator status.
4. The foundation does not fund investigators who have substantial (more than $200,000 per year) extramural funding calculated as total direct funds per year less any PI salary/fringe taken from these grants. If this amount is greater than $200,000, the PI is not be eligible for Whitehall Foundation funding. As of December 1, 2024, the foundation no longer includes indirect funding in the extramural funding calculation. Startup funds and internal funding should be disclosed but are not included in the extramural funding calculation.

It is the Whitehall Foundation’s policy that an investigator must be in place, working at their institution with the appropriate title, when the letter of intent is submitted.

Grants in Aid
The Grants-in-Aid program is designed for researchers who experience difficulty in competing for research funds because they have not yet become firmly established. All applications will be judged on the scientific merit and innovative aspects of the proposal, as well as on past performance and evidence of the applicant’s continued productivity. Grants-in-Aid are awarded for a one-year period and do not exceed $30,000.

Applicants for the Grants-in-Aid program are reviewed and ranked together with the traditional research grant program. This program is not a prerequisite to a two- or three-year research grant. The majority of the applications received are for a three-year research grant.

---

Campbell Foundation – Limited Submission

Deadline: October 1, 2026
Due to our funding limitations, we are only able to consider LOIs from one research team at any given institution within a one-year time frame.

Funding:
Most grant funding is between $60,000 and $100,000. The foundation has co-funded and has provided partial funding for more costly research projects.

Purpose:
The Campbell Foundation invites letters of intent for its research grants that support novel research relevant to the HIV community at large within five to seven years from date of completion.

It was Mr. Zahn's wish that his private, independent foundation support nonprofit organizations conducting clinical, laboratory-based research into the prevention and treatment of HIV/AIDS, and related conditions and illnesses.

Eligibility:
Funding is restricted to those organizations providing proof of IRS 501(c)(3) status. Applications are not accepted from individuals or for-profit entities.

Additional deadlines: LOIs are accepted during January, April, July and October of each year.

---

McKnight Foundation – Neurobiology of Brain Disorders Award

Deadline: October 15, 2026, 5 p.m. CT

Funding: $100,000 per year for three years

Purpose
For scientists translating laboratory discoveries about the brain and nervous system into diagnoses and therapies to improve human health.

Eligibility
A candidate for a McKnight Neurobiology of Brain Disorders Award must work as an independent investigator at a not-for-profit research institution in the United States, must have held a tenured or tenure-track faculty position for at least three years at the time of application (no later than September 2023), and must wait at least one year before reapplying after two unsuccessful concurrent applications.

---

CurePSP

Deadline: October 15, 2026, at 5 p.m.

Funding: Up to $100,000 for one or two year studies

Career Stage: Early career

Purpose:
CurePSP will fund studies on PSP and CBD through two avenues, the pathway grants or pipeline grants program.

Pathway grants support projects studying the fundamental neurobiology of PSP and CBD.  A more complete understanding of the underlying basic science and mechanisms of PSP and CBD will improve understanding of the diseases and provide the foundation for future treatments. Studies focusing on mechanisms common to multiple neurogenerative conditions are strongly encouraged. Examples of pathway grant topics include (but are not limited to) tau biology and pathobiology, epigenetics and epigenomics, synaptic dysfunction/lost and pruning, neuroinflammation, organoids, or other underlying mechanisms of PSP or CBD.

Pipeline grants support translational projects focusing on new therapeutics and biomarkers for PSP and CBD. These projects will accelerate the development of therapeutics that have the potential to prevent, treat or cure PSP and CBD by accelerating the translation of basic science discoveries into novel therapeutics. Examples of pipeline grant topics include (but are not limited to) symptomatic drug trials, diagnostic markers, or rehabilitation strategies for motor and nonmotor deficits.

Eligibility:
The Pathway and Pipeline program is open to early-career investigators. For the purposes of this grant, early career investigators include those with job titles such as assistant professor, research assistant professor or equivalent independent research position. Postdoctoral fellows and medical fellows are eligible to apply, provided this project is intended to support a transition to an independent research career.

Klingenstein Philanthropies
Fellowship Awards in Neuroscience

Deadline: November 20, 2026, 11:59 p.m.

Funding: $50,000 per year over two years

Career Stage: Postdoctoral

Purpose:
Investigating the causes, prevention, and treatment of children and adolescents with ADHD or depression, especially those from low-income families and under-resourced communities, or other minoritized populations that may have limited supports and resources. The fellowship supports two-year research projects that could lead to federal funding and other national research awards. The foundation supports research that produces direct and tangible benefits to children and their families, while also supporting promising early-career scientists. We encourage postdoctoral or junior faculty candidates from underrepresented and minoritized groups and/or with lived experience applicable to their work to apply.

Eligibility:
Candidates must hold a PhD or MD and have completed all clinical training in their field. Candidates should be at the postdoctoral or junior faculty level on a trajectory for attaining faculty status. The foundation will consider investigators who are in T32 or other designated research training programs.

Cancer Research Institute
CRI Clinical Innovator: Advancing Breakthrough Immunotherapy Trials to Transform Patient Care

Deadline: December 1, 2026, protocol concept. If invited, full proposal due April 1, 2027

Funding: $1M per trial

Career Stage: Early Career

Purpose:
The CRI Clinical Innovator supports pioneering immunotherapy clinical trials designed and led by academic researchers. These investigator-initiated studies are vital to improving patient outcomes, addressing areas of high unmet need, and generating critical mechanistic insights that can guide the future of cancer treatment.

Eligibility:
Candidates must be the principal investigator (PI) of the proposed study. CRI has no citizenship restrictions, and research supported by the award may be conducted at medical schools or research centers in the United States or abroad.

---

Cancer Research Institute Clinic and Laboratory Integration Program

This multi-investigator team science project aims to bridge the gap between basic mechanistic discovery and clinical application of innovative immune prevention or interception of primary cancer development and cancer recurrence after successful primary cancer treatment.

Deadline: December 1, 2026, letter of intent; if invited, full proposal due March 1, 2027

Funding: Up to $1,000,000 over three years

Purpose: The CRI Clinic and Laboratory Integration Program (CLIP) supports innovative, team-based investigations at the intersection of laboratory discovery and clinical application in cancer immunology. CLIP is designed to accelerate the translation of scientific discoveries into approaches that can improve outcomes for patients with cancer.

Eligibility: Candidates for a CRI CLIP Grant must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation. If not, documentation from their institution must accompany the letter of intent indicating they will hold the position of assistant professor (or higher rank) by the time of award activation.

---

American Cancer Society (ACS)
Mission Boost Grants

Deadline:
Winter cycle: December 1
Summer Cycle: June 1

Career Stage: All career stages

Funding:
Stage I: $135,000 for two years
Stage II: $545,000 direct costs plus 10% allowable indirect costs, over 18 months

Purpose: Mission Boost Grants (MBG) are designed to support research projects that specifically focus on translation to human testing. MBGs are opportunities for independent investigators at all levels to apply for additional, or "boost," resources for innovative, clinical-enabling projects.

Eligibility:

Stage I Mission Boost

We no longer require MBG applicants to be current or former ACS grantees or fellows. Starting in 2025, you ARE eligible to submit a proposal for a Stage I grant if you:

• Work at an academic institution in the United States or eligible nonprofit 
• Are an independent investigator with a full-time faculty appointment (or equivalent). Applicants may be at any career stage.
• Applicants may submit only one MBG I or MBG II application per cycle, and applicants may not submit RSG, DBG, or CSDG applications in the same cycle as a MBG submission.

Stage II Mission Boost

You ARE eligible to submit a proposal for a Stage II grant if you:

• Work at an academic institution in the United States or eligible nonprofit 
• Are an independent investigator with a full-time faculty appointment (or equivalent). Applicants may be at any career stage.
• Previously held or currently hold a Stage I Mission Boost Grant for a minimum of 18 months AND have completed Stage I milestones
• Applicants may submit only one MBG I or MBG II application per cycle, and applicants may not submit RSG, DBG, or CSDG applications in the same cycle as a MBG submission.

---

American Cancer Society (ACS)
Research Scholar Grants

Deadline:
Winter cycle: December 1
Summer Cycle: June 1

Career stage: Researchers within the first eight years of independent research

Funding: $215,000 a year for up to four years

Research Scholar Grants (RSG) provide support for independent, self-directed researchers. Applicants' institutions must provide space and other resources customary for independent investigators. Grant proposals are investigator-initiated and may pursue questions across the cancer research continuum, as long as they fit within an American Cancer Society (ACS) priority research area.

These grants typically contribute to the cost of salaries, consumable supplies, and other miscellaneous items required in the research.  

Eligibility:

• Work at a U.S.-based academic or eligible nonprofit institution
• Serve as PI on no more than one R01 or R01 equivalent grant at the time of application

Note: ACS updates RSG cycles regularly.

---

American Cancer Society – Postdoctoral Fellowships

Deadline: December 1, 2026

Funding: Progressive stipends of $66,000, $68,000, and $70,000 for up to three years, plus an annual $4,000 fellowship allowance and $1,500 travel allowance in the final year.

Purpose: Postdoctoral fellowships support new investigators in research training programs to position them for independent careers in cancer research. As part of their evaluation, peer reviewers consider how well the fellowship will broaden the applicant’s research training and experience.

Eligibility: Investigators who are U.S. citizens or non-citizens holding an appropriate visa when the application is submitted and who have completed three or fewer years of postdoctoral research training.

---

---

W.M. Keck Foundation – Limited Submission

Deadline: December 7, 2026

New Application Process:
The W. M. Keck Foundation Research program is introducing a new six-month application cycle to enable more responsive grantmaking and create a streamlined process for applicants.

Important changes to be aware of:

• Concepts: We will no longer be hosting concept consultations.
• Single-phase application: A single proposal submission replacing our current multi-stage process.
• Deadlines: Submission deadlines in December and June
• Application limits: Up to three applications per institution, not limited to any area of science.

Instructions for constructing and submitting proposals will be available in September.

Funding:

• Typical awards: $1 million to $1.3 million over three years
• Two limited submission funding cycles per year
• No indirect costs — institution provides in-kind support by waiving indirects

Funding Priorities

• High-impact research in basic physical, life and biomedical sciences, including instrumentation and engineering in service of basic science.
• Pioneering, fundamental discoveries in important and emerging research areas
• Novel approaches that are distinctive, innovative, field-expanding and challenge existing paradigms
• High-risk, high-reward proposals are welcome

Eligibility:

• PIs must be tenure-track faculty or equivalent (normally eligible to submit proposals without exceptional approvals)
• Past grantees may apply on significantly different projects
• No resubmission of declined proposals
• No follow-on funding for previous awards

---

Elsa U. Pardee Foundation

Deadline: December 1, 2026

Career Stage: Early and established career

Funding:
By design, there are no limits set on the amount that can be requested. It must be reasonably supported by the scope of the project outlined in the application. Indirect costs cannot exceed 5% of the total amount requested.

Description:
The Elsa U. Pardee Foundation funds research to investigators in United States nonprofit institutions proposing research directed toward identifying new treatments or cures for cancer. The foundation funds projects for a one-year period, which will allow the establishment of capabilities of new cancer researchers or new cancer approaches by established cancer researchers. It is anticipated that this early-stage funding by the Foundation may lead to subsequent and expanded support using government agency funding. Project relevance to cancer detection, treatment or cure should be clearly identified. The foundation particularly welcomes innovative, small-scale, short-term projects that may be difficult to fund elsewhere until some interesting results are obtained.

Eligibility:
Priority is given to researchers at nonprofit institutions in the United States who are new to the field of cancer research, or to established research investigators examining new approaches to cancer cure.

---

Harrington Discovery Institute
Brain Health Medicines

Upcoming Deadline: December 31, 2026

Additional deadlines:

• March 31, 2027
• June 30, 2027
• September 30, 2027

Funding: $100,000

Purpose:
The Brain Health Medicines Scholar Award seeks discoveries demonstrating rigorous science, creativity, innovation and potential for clinical impact, any therapeutic modality
and novel, validated targets. The award provides funding and drug development support to researchers whose work aims to treat, prevent or cure Alzheimer's disease and related dementias. The award includes:

• Potential to renew for a second year based on milestones achieved
• Dedicated project manager for the duration of the award
• Drug development, commercial strategy and business development support from Harrington's Therapeutics Development Center experts
• Opportunity to quality for up to $400,000 in additional funding and drug development support

Eligibility

• MD or PhD (or equivalent).
• Faculty position at an accredited academic medical center, university or research institution in the U.S., Canada or the U.K., and conduct the majority of their research at that institution.
• A project must have a single principal investigator (PI) who will be named the scholar and who is responsible for project oversight and financial management. The PI may engage collaborators, core labs or commercial CROs to execute any portion of the project.

Campbell Foundation – Limited Submission

Deadline: Internal deadline TBA.
Due to our funding limitations, we are only able to consider LOIs from one research team at any given institution within a one-year time frame.

Funding:
Most grant funding is between $60,000 and $100,000. The foundation has co-funded and has provided partial funding for more costly research projects.

Purpose:
The Campbell Foundation invites letters of intent for its research grants that support novel research relevant to the HIV community at large within five to seven years from date of completion.

It was Mr. Zahn's wish that his private, independent foundation support nonprofit organizations conducting clinical, laboratory-based research into the prevention and treatment of HIV/AIDS, and related conditions and illnesses.

Eligibility:
Funding is restricted to those organizations providing proof of IRS 501(c)(3) status. Applications are not accepted from individuals or for-profit entities.

Additional deadlines: LOIs are accepted during January, April, July and October of each year.

---

The Mathers Foundation - Limited Submission

IMPORTANT: Institutional nomination is required to apply. Each institution may nominate up to three researchers (principal investigators) per cycle. Institutional nominations are required at least two weeks before the current cycle’s due date. The designated administrative contact must email the nominees’ names and project titles to grants@mathersfoundation.org.
Deadlines:
Institutional Nominations and Portal Registration

• January 28, 2027, 8 p.m. ET
• Anticipated: July 17, 2027, 8 p.m. ET

LOI application due date::

• February 11, 2027, 8 p.m. ET. If invited, full proposal due April 15, 2027, 8 p.m. ET
• Anticipated: July 31, 2027, 8 p.m. ET. If invited, full proposal due September 18, 2027, 8 p.m. ET

Funding: $600,000-700,000, inclusive of 10% indirect costs, over three years

Purpose:
Research areas supported include immunology, microbiome, structural biology, cellular physiology, cancer biology, genetics, genomics, microbiology and infectious diseases, stem cell biology and n euroscience. The list is not exhaustive and may be subject to change or interpretation by the board.

Eligibility:

• Institutions that directly support their own investigators
• Principal investigators with their own fully equipped labs
• Professor-level faculty appointment
• Collaborative research projects with other U.S.-based organizations

---

Cancer Research Institute – CRI Lloyd J. Old STAR Program

Deadline: January 15, 2027

Funding: $1.25 million over a five-year period; indirect costs of up to 10%

Purpose:
The CRI Lloyd J. Old STAR program — Scientists TAking Risks — provides long-term, flexible funding to mid-career scientists, giving them the freedom to pursue high-risk, high-reward research at the leading edge of cancer immunotherapy.

Eligibility:
The applicant must have an MD, PhD, or MD/PhD (or equivalent). Candidates must hold a tenure-track position. Assistant professors with a minimum of three years in that role and associate professors with a maximum three years may apply. Applicants are expected to commit a minimum of 80% of their time to conducting research.

Cancer Research Institute
CRI IGNITE Award: Inspiring Growth and Nurturing Independence Through Excellence

Deadline: February 1,2027, 11:59 p.m. ET

Supports early faculty as they launch new labs and pursue bold, high-impact research in cancer immunology.

Career Stage: Postdoctoral

Purpose:
The CRI IGNITE Award — Inspiring Growth and Nurturing Independence Through Excellence — supports the transition of outstanding postdoctoral researchers into independent tenure-track investigators. The program offers two sequential phases of funding.

Funding:
Phase 1: IGNITE Foundation Phase

• Up to two years: $150,000 per year
• Provides $90,000 a year in salary support, and $60,000 to fund independent work
• Provides critical protected time, mentorship and research support to help postdocs prepare for independence

Phase 2: IGNITE Independence Phase

• Up to three years, $250,000 per year
• Funding is contingent upon an adequate start-up package by the host institution

Eligibility:

• Must be in a mentored postdoctoral position at time of application
• No more than five years of postdoctoral experience at time of application. Candidates with more than five years of postdoctoral experience may be granted an exception. Contact CRI for more information.
• Must commit to a minimum of 12 months of mentored research before transition
• Open to U.S. and international researchers; CRI does not have citizenship requirements.
• May conduct research in the U.S. or abroad.
• Have not currently or previously held an independent research faculty or tenure-track faculty position, or its equivalent, in academia, industry or elsewhere

Cancer Research Institute
CRI Immuno-Informatics Postdoctoral Fellowship: Cultivating the Next Generation of Leaders at the Intersection of Immunology and Data Science

Deadlines: March 1, 2027, September 1, 2027

Funding: $228,000 over three years

Career Stage: Postdoctoral

Purpose:
The CRI Immuno-Informatics Postdoctoral Fellowship program supports outstanding early-career scientists worldwide who seek dual expertise in immunology and data science. This unique program fosters a new generation of researchers fluent in both biology and computation, equipping them to drive innovation in cancer immunotherapy.

Eligibility:

• Applicants must have a doctoral degree by the date of award activation and must conduct their proposed research under a sponsor who holds a formal appointment as an assistant professor or higher rank at the host institution.
• Applicants must be working in areas directly related to immunology or cancer immunology. An eligible project must fall into the broad field of immunology with relevance to solving the cancer problem.
• Applicants who will have five or more years of mentored research experience at the time of award activation are not eligible, with the exception of MD applicants, who should not include years of residency in this calculation. Applicants should use their doctoral degree conferral date when calculating eligibility.

---

Cancer Research Institute
CRI Irvington Postdoctoral Fellowship Program – LIMITED SUBMISSION

Deadline: March 1, 2027

Funding:
Fellowships provide three years of support, including a stipend of $74,000, $76,000, and $78,000 in years 1 through 3. The host institution receives a $5,000 annual allowance for use at the sponsor’s discretion to cover costs such as research supplies, conference travel, health insurance or childcare.

Purpose:
The CRI Irvington postdoctoral fellowship program supports outstanding young researchers at the world’s leading universities and research institutions, providing the resources, mentorship and professional development needed to launch independent scientific careers at the forefront of discovery.

Eligibility:

• Applicants must have a doctoral degree by the date of award activation and must conduct their proposed research under a sponsor who holds a formal appointment as an assistant professor or higher rank at the host institution.
• Applicants must be working in areas directly related to immunology or cancer immunology. An eligible project must fall into the broad field of immunology with relevance to solving the cancer problem.
• Applicants who will have five or more years of mentored research experience at the time of award activation are not eligible, with the exception of MD applicants, who should not include years of residency in this calculation. Applicants should use their doctoral degree conferral date when calculating eligibility.
• Only in exceptional circumstances will applicants who have already spent three or more years in a sponsor’s laboratory by the start date of thefellowship be considered for a fellowship award.
• The fellowship can be performed in the United States or abroad but must take place at a nonprofit institution. There are no citizenship restrictions.
• Only one fellow per sponsor may apply per application round, and faculty sponsors may not have more than three CRI-supported fellows at any time.

Pew Biomedical Scholars  - Limited Submission

Deadlines: Pending announcement from foundation in early April 2027

Funding: $300,000; $75,000 per year for a four-year period.

Purpose: Based on their performance during their education and training, candidates should demonstrate outstanding promise as contributors in science relevant to human health. This program does not fund clinical trials research. Strong proposals will incorporate particularly creative and pioneering approaches to basic, translational and applied biomedical research. Candidates whose work is based on biomedical principles but who bring in concepts and theories from more diverse fields are encouraged to apply.

Eligibility:

• Hold a doctorate in biomedical sciences, medicine or a related field, including engineering or the physical sciences.
• As of September 3, 2025, run an independent lab and hold a full-time appointment at the rank of assistant professor. Appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor or instructor are not eligible.

W.W. Smith Charitable Trust – Limited Submission

A maximum of one proposal per parent organization may be submitted in each granting category (i.e., heart disease, cancer or AIDS) regardless of the number of EINs available under the organization.

Deadline: July 15, 2027, 11:59 p.m. ET

Funding: $100,000 to $125,000

Purpose:
The trust awards grants for basic medical research primarily related to heart disease, cancer and AIDS. The trust invests in promising researchers having the potential to attract larger-scale awards (e.g., NIH, NSF, AHA) subsequent to trust support.

Eligibility:
It is up to each organization to conduct an internal selection process to determine the one principal investigator/research project to represent the institution for each discipline.

Simons Foundation – New Ideas Award

Deadline: Letters of intent (LOI) will be accepted on a rolling basis

Funding: $300,000 per year for up to two years; includes 20% indirect costs

Purpose:
The goal of the New Ideas Award is to provide early-stage support for bold, exploratory research that tests novel hypotheses and opens new conceptual or experimental directions in the study of autism and related neurodevelopmental disorders. Proposed research may draw on any scientific discipline, methodology or experimental system (including humans), and may operate at any scale or level of analysis. All projects should include a compelling case for the relevance and potential of the proposed experiments to SFARI’s mission. Investigators who have not previously been funded by SFARI are especially encouraged to apply.

Eligibility
All applicants and key collaborators must hold a PhD, MD or equivalent degree and have a faculty position or the equivalent at a college, university, medical school or other research facility. We encourage both applicants who have long been working in autism research and those new to the field.

---

Michael J. Fox Foundation
Parkinson’s Disease Therapeutics Pipeline Program

Deadline:

• Applicants may submit a pre-proposal application at any time. Pre-proposals will be reviewed by MJFF within three weeks of submission.
• If invited, full proposal is to be submitted through one of the five review cycles:
  • April 23, 2026
  • June 25, 2026
  • August 20, 2026

Funding: $250,000 for smaller, targeted programs to upwards of $2M for larger, multi-stage preclinical and/or clinical programs.

Purpose:
This program seeks to advance therapeutic development through pre-clinical and/or clinical testing of approaches addressing unmet needs of people with Parkinson’s disease (PD). The program is set up to benefit therapeutics with clear potential to prevent, stop or delay disease progression or to reduce the burden of daily symptoms.

MJFF prioritizes pre-clinical and clinical programs that may slow, stop or prevent disease
progression, efforts that address moderate-to-advanced motor or non-motor symptoms of
Parkinson’s not well-managed by current treatments, such as advanced gait disturbances (e.g., balance issues linked to falls, freezing), and cognitive changes. Activities within scope of this program include:

• Pre-clinical: Identifying, validating and/or developing novel pharmacological and nonpharmacological interventions through pre-clinical development from early screening to pre-clinical characterization and testing.
• Clinical: Progressing promising interventions with strong preclinical packages into/through initial clinical assessment exploring pharmacokinetics and pharmacodynamics, safety/tolerability, or early proof of biology and/or clinical efficacy. For novel targets, MJFF is particularly interested in de-risking programs by supporting early proof of concept in patients to gain insight into the therapeutic potential, including exploration of biomarker-based or clinical endpoint-based efficacy

Eligibility:
The foundation is only accepting applications from industry groups or academic teams working in collaboration with a dedicated industry partner capable of further commercial development of a promising intervention. Further, our goal is to provide funding to de-risk therapeutic programs and catalyze investment by other funders. We do not anticipate serving as the sole funder for any program and encourage applicants to seek additional financial partnerships.

---

Michael J. Fox Foundation

The Alzheimer’s Association and the Michael J. Fox Foundation for Parkinson’s Research are launching the Bridge Funding for Disrupted Neurodegenerative Research (BFDN) grant program.

Deadline: 15th of the month (or the following Monday, if the 15th falls on a weekend).
If invited, full proposal deadline will be within four weeks of receiving the invitation by 5 p.m. ET. If invited, full proposal deadline will be within four weeks of receiving the invitation by 5 p.m. ET.

Funding: Principal investigators may apply for bridge funding spanning three to 12 months for U.S. and international projects impacted by changes in the NIH.

Career Stage: Early Career

Purpose:
This program specifically aims to 1) ensure support for early career researchers (based on NIH definition), who have not yet had the opportunity to fully establish their labs and position their projects for ongoing funding, and 2) provide bridge or interim funding for salary and other direct costs for research projects focused on Alzheimer’s disease, frontotemporal dementia, Parkinson’s disease, dementia with Lewy bodies, atypical Parkinson's and/or other related disorders that have been impacted by a series of changes at NIH.

---

Cardiovascular Medical Research and Education Fund
Improving the Treatment of Pulmonary Diseases

Deadline: Rolling

Funding:
Preference will be given to proposals that have budgets below $100,000 and timelines less than two years.

Purpose:
The CMREF mission of the fund is to support educational activities that will enhance the knowledge of pulmonary hypertension and research projects that may help uncover the causes and pathogenesis of idiopathic pulmonary arterial hypertension (IPAH) in pursuit of the ultimate goal of its treatment and cure. The CMREF does not have a formal application process to fund clinical research or educational projects but is always interested in potentially providing full or partial support to initiatives that are novel, innovative or address the spectrum of unmet medical needs related to pulmonary vascular diseases.

Interested parties should submit a letter of intent (maximum of two pages) that describes the project sufficiently so that the Research Advisory Committee can understand the proposed goals and methods. In addition, the letter should mention the length of time of the project and an estimated overall budget.

How to Apply:
To submit your letter, please use the form on this page. Please be sure to fill out all fields and upload your letter before submitting. You can also email your letter directly to Patt Wolfe (executive director) at patt.wolfe@ipahresearch.org.

After you submit your letter, the CMREF will respond within four weeks to inform you if a full application will be requested.

---

American Federation for Aging Research
Medical Student Training in Aging Research (MSTAR) Program

Deadline:
Interested students should be in touch directly with the National Training Centers to for the program deadline and application materials.

Funding:
The stipend level is approximately $1,980 per month; actual amounts will vary based on the specific appointment period of individual students. Award period: Eight to 12 weeks.

Purpose:
The MSTAR Program provides medical students with an enriching experience in aging-related research and geriatrics, with the mentorship of top experts in the field. This program introduces students to research and academic experiences early in their training that they might not otherwise have during medical school. Positive experiences in the MSTAR program have led many physicians-in-training to pursue academic careers in aging, ranging from basic science to clinical research to health services research. They have joined the growing cadre of physicians and scientists whose specialized knowledge and skills are in great demand as our population ages.

Students participate in an eight- to twelve-week (or two- to three-month, depending on the training site) structured research, clinical and didactic program in geriatrics, appropriate to their level of training and interests. Research projects are offered in basic, translational, clinical or health services research relevant to older people. Most scholars will do their training and research during the summer months. They will also be invited to submit an abstract to present a poster at the annual meeting of the American Geriatrics Society.

Eligibility

• Any allopathic or osteopathic medical student in good standing, who will have successfully completed one year of medical school at a U.S. institution by June 2024. Evidence of good standing must be provided by the medical school registrar or dean when the student is notified of receiving the award.
• Applicants must be citizens or non-citizen nationals of the United States, or must have been lawfully admitted for permanent residence (i.e., in possession of a currently valid Alien Registration Receipt Card I-551, or some other legal verification of such status). Individuals on temporary or student visas are not eligible. Due to NIA restrictions, individuals holding PhD, MD, DVM or equivalent doctoral degrees in the health sciences are not eligible to apply to do the MSTAR Program.
• Additionally, applicants receiving a stipend or salary support from a federal source are not eligible for this program. Applicants may not hold another award or participate in another program concurrently with the MSTAR program, and must participate in the program full-time for a minimum of eight weeks and a maximum of 12 weeks.

---

Infectious Diseases Society of America
Grants for Emerging Researchers/Clinicians Mentorship Program

Career Stage: Medical Students

Amount: Not specified

Deadline: Ongoing

Description
The G.E.R.M. Program was developed to provide grants to medical students to support a longitudinal, mentored clinical learning and/or research project for up to a year on infectious diseases-related topics, including HIV, under the mentorship of an IDSA or HIVMA member. This program replaced the IDSA Medical Scholars and HIVMA Medical Students Programs.

Eligibility

• Graduate students
• Applicants must be medical students (first-, second- or third-year and those in combined degree programs, including MD/MPH and MD/PhD) from an accredited allopathic or osteopathic medical school in the U.S.

 Back to Top